Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Cancer cells can overcome replicative senescence by activating the alternative lengthening of telomeres (ALT) pathway. ALT positive cancer cells are uniquely characterized by the production of circular C-rich telomeric DNA sequences (C-circle). This protocol describes how to detect C-circles isolated from ALT-positive mammalian cells.

Abstract

The identification of cancer cells that promote telomere elongation in the absence of telomerase activity led to the identification of the alternative lengthening of telomeres (ALT) pathway. The ALT pathway is active in approximately 10-15% of all human cancers. However, ALT is most prevalent in some of the most aggressive forms of human cancer including, glioblastoma, osteosarcoma, and pancreatic neuroendocrine tumors. These cancers are highly refractory to common therapeutic strategies and have poor overall survival. Therefore, there has been a growing interest in understanding how, and under what conditions, the ALT pathway is active in an effort to identify therapies that uniquely target the ALT mechanism. These efforts necessitate the use of a robust biomarker to not only identify ALT positive cancers, but also to monitor ALT activity throughout treatment. Several cellular phenotypes have been identified and demonstrated to correlate with ALT activity including the production of extrachromosomal telomeric repeat (ECTR) DNA. ECTR exist in both linear and circular forms containing either C-rich or G-rich partially double-stranded telomeric sequences. To date, the circular C-rich telomeric sequences (C-circles) are the only ECTR DNA products that have been demonstrated to be exclusive to ALT positive cancer cells. In this protocol, we demonstrate a technique used to isolate and detect C-circles from mammalian cells highlighting the utility of this assay in the determination of ALT status.

Introduction

Telomeres are repetitive DNA sequences that cap the ends of linear chromosomes to protect chromosome ends from degradation and end-to-end fusions. Given the semiconservative nature of DNA replication telomeres shorten with each successive cell division. Eventually, telomeres reach a critically short length and induce cellular senescence and crisis. Cancer cells must overcome telomere shortening to bypass cellular senescence and gain replicative immortality.1 Approximately 85% of cancers promote telomere elongation by reactivating the enzyme telomerase.2 Another 10% of cancers activate a second mechanism called t....

Protocol

1. Isolate genomic DNA

  1. Collect cells from a 10 cm dish with trypsin or by scraping and collect in a microcentrifuge tube.
    1. Wash cells with 3-5 ml of PBS.
    2. If collecting cells by scraping, scrape dish and collect. Otherwise, aspirate PBS from dish.
    3. Add 1.5 ml of 0.05% trypsin-EDTA and incubate at 37 °C for 3-5 min or until cells detach from plate.
    4. Add 5-10 ml of media containing 10% fetal bovine serum and wash the plate.
      NOTE: This step is only necessary .......

Representative Results

Cells that rely on the ALT pathway for telomere maintenance are characterized by a number of cellular phenotypes, including the formation of partially single-stranded circular C-rich telomeric DNA. C-circles are unique to ALT cells and can be detected using rolling circle amplification of genomic DNA isolated from mammalian cells as depicted in Figure 1. Figure 2A is a representative experiment demonstrating the detection C-circle products in the ALT positive U2OS and telomerase positive .......

Discussion

The identification of cancer cells that maintain telomere length for over 100 population doublings in culture, in the absence of telomerase activity, led to the identification of the ALT pathway3. Since that initial discovery twenty years ago there has been a growing interest in defining mechanistically how, and under what conditions, the ALT pathway is active in cancer. To date, the literature suggests that the ALT pathway is active in approximately 10-15% of all human cancers, with the highest p.......

Acknowledgements

We thank members of the R.L.F. lab for review of the manuscript. R.L.F. is supported by the NIH Pathway to Independence Award (CA166729), the Karin Grunebaum Cancer Research Foundation, Peter Paul Professorship, and the Edward Mallinckrodt Jr. Foundation. E.M.O was also supported by the NIGMS T32 funded Program in Biomolecular Pharmacology (3T32GM008541-18S1).

....

Materials

NameCompanyCatalog NumberComments
MicrocentrifugeAny microcentrifuge will work, eg. Eppendorf 5424
NanodropThermo Scientific2000Any DNA quantitation spectrophotometer is sufficient
Water bathA heat block can be used in place of a water bath for incubations
ThermocycleAny thermocycler is sufficient, e.g. BioRad C1000 touch
Dot blot apparatusBioRad1706545
UV CrosslinkerAny UV Crosslinker is sufficient, e.g. Boekel Scientific 234100
Hybridization bagsAny boilable heat seal pouch will work, e.g. Kapak Sealpak  
Hybridization ovenAny hybridization oven is sufficient, e.g. Thermo Scientific Shake 'n' Stack
Glass hybridization bottleAny hybridization bottle that fits the rotisserie in the hybridization oven, e.g. Wheaton borosilicate glass hybridization bottle
Autoclave
Chemiluminscent imagerAny chemiluminescence imager is sufficient, e.g. BioRad ChemiDoc XRS+with Image Lab software
Impulse heat sealerAny impulse heat sealer is sufficient, e.g. FS-305 impulse sealer 
D-PBS (1X)Invitrogen14190-144Any PBS can be used to wash cell pellet
0.05% Trypsin-EDTA Thermo Scientific25300062 Any cell dissociation reagent is sufficient, use reagent approriate for the cell line
QIAmp DNA Mini kitQiagen51304
Alu1New England BiolabsR0137L
Mbo1New England BiolabsR0147L
CutSmart Buffer (10X) New England BiolabsB7204SBuffer is normally supplied with restriction enzymes
PureLink Rnase AInvitrogen12091-021
GeneJET PCR Purification Kit Thermo ScientificK0701Qiagen QIAquick PCR purification kit can be used without effect on assay outcome
Bovine Serum Albumin SigmaA2153Any BSA is sufficient 
phi29 DNA polymeraseNew England BiolabsMO269L
phi29 DNA  pol reaction buffer (10X)New England BiolabsBO269SBuffer is normally supplied with polymerase
Tween-20SigmaP1379Any Tween 20 is sufficient
dATP solution (100mM)Invitrogen55082
dTTP solution (100mM)Invitrogen55085
dGTP solution (100mM)Invitrogen55084
Sodium ChlorideSigmaS5886Any sodium chloride is sufficient
Sodium citrate tribasic dihydrateSigmaS4641
Chromatography paperFisherbrand05-714-4Any chromatography filter paper is sufficient
Amersham Hybond-XLGE HealthcareRPN 203 S
ULTRAHyb Ultrasensitive Hybridization bufferInvitrogenAM8670Warm in water bath to 65° C before use
Sodium dodecyl sulfateFisher ScientificBP166Any SDS is sufficient
Telomere probe (5' - CCCTAACCCTAACCCTAACCCTAA - 3')Invitrogen25nmoles; standard desalting; resuspend at 250µM
DIG oligonucleotide 3' - End labeling kit, 2nd generationRoche3353575910Kit contains 5X reaction buffer, CoCl2 solution, DIG-ddUTP solution and recombinant terminal transferase
EDTASigma6381-92-6Any EDTA is sufficient
Maleic AcidSigma110-16-7Any maleic acid is sufficient
Blocking ReagentRoche11096176001
Tris-HClSigma77-86-1Any Tris-HCl is sufficient
anti-Digoxigenin-AP Fab fragmentsRoche11093274910
CDP-StarRoche11759051001

References

  1. Hanahan, D., Weinberg, R. A. Hallmarks of cancer: the next generation. Cell. 144 (5), 646-674 (2011).
  2. Shay, J. W., Bacchetti, S. A survey of telomerase activity in human cancer. Eur J Cancer. 33 (5), 787-791 (1997).

Explore More Articles

TelomeresCancerAlternative Lengthening of TelomeresBiomarkerExtra Chromosomal Telomeric Repeatscircular DNA

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved